The DOI matches its Crossref record.
Hepatogastroenterology
Abstract
BACKGROUND/AIMS: Monotherapy with pegylated interferon alpha (Peg-IFNa) or adefovir dipivoxil (ADV) to HBeAg-positive chronic hepatitis B (CHB) patients has limited effects. This study aims to evaluate therapeutic efficacy and safety of individualized combination therapy with Peg-IFNa and ADV. METHODOLOGY: HBeAg-positive CHB patients (n=160) were enrolled in this multi-center, prospective, randomized, 'real-life' cohort study, of which received Peg IFNa-2a monotherapy or combination therapy with ADV base on the baseline features and treatment response. RESULTS: At week 24, percentages of ALT normalization, HBV DNA undetectable were both higher in individualized treatment group (ITG, 57.50%, 43.75%) than that in standard treatment group (STG, 40.00%, 27.50%; p=0.027, 0.032). The superiority of HBeAg clearance and seroconversion rates in ITG maintained from treatment termination (63.75%, 56.25%) to 48 weeks follow-up (57.50%, 53.75%). At week 96 the combined response rates were 46.25% in ITG compared with 30.00% in STG (p=0.034). Furthermore, there was no statistically significant difference in relapse rates and adverse events between the two groups. CONCLUSIONS: Individualized combination therapy can achieve higher antiviral response rates. In particular, it can accelerate undetectable HBV DNA and elevate HBeAg clearance/seroconversion rates to a greater degree than Peg-IFNa-2a monotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
Epidemiology and Management of Liver Metastases From Colorectal Cancer
Manfredi, S., Lepage, C., Hatem, C., Coatmeur, O., Faivre, J., & Bouvier, A.-M. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217629.94941.cf · Cited by 1,394
Yeo, C. J., Cameron, J. L., Lillemoe, K. D., Sohn, T. A., Campbell, K. A., Sauter, P. K., Coleman, J., Abrams, R. A., & Hruban, R. H. (2002) · Annals of Surgery · doi:10.1097/00000658-200209000-00012 · Cited by 807
THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions
Satoh, T., & Hosokawa, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.257 · Cited by 758
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
Horgan, A. M., Amir, E., Walter, T., & Knox, J. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.5381 · Cited by 716
Subclinical hepatic encephalopathy impairs daily functioning
Groeneweg, M., Quero, J. C., De Bruijn, I., Hartmann, I. J. C., Essink-bot, M.-L., Hop, W. C. J., & Schalm, S. W. (1998) · Hepatology · doi:10.1002/hep.510280108 · Cited by 506
Rayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476
Thoeni, R. F. (2012) · Radiology · doi:10.1148/radiol.11110947 · Cited by 470
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Masoodi, M., Gastaldelli, A., Hyötyläinen, T., Arretxe, E., Alonso, C., Gaggini, M., Brosnan, J., Anstee, Q. M., Millet, O., Ortiz, P., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00502-9 · Cited by 451
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
Erstad, D. J., & Tanabe, K. K. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07227-9 · Cited by 428
Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy
Romero-Gómez, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02692-2 · Cited by 411
Lieber, C. S., & Leo, M. A. (1992) · Medical and Nutritional Complications of Alcoholism · doi:10.1007/978-1-4615-3320-7_7 · Cited by 407
Grams, R. J., Santos, W. L., Scorei, I. R., Abad-García, A., Rosenblum, C. A., Bita, A., Cerecetto, H., Viñas, C., & Soriano-Ursúa, M. A. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00663 · Cited by 377
Grazi, G. L., Ercolani, G., Pierangeli, F., Del Gaudio, M., Cescon, M., Cavallari, A., & Mazziotti, A. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00011 · Cited by 341
Shakhar, G., & Ben-Eliyahu, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.02.007 · Cited by 327
Patient-derived xenograft (PDX) models, applications and challenges in cancer research
Abdolahi, S., Ghazvinian, Z., Muhammadnejad, S., Saleh, M., Asadzadeh Aghdaei, H., & Baghaei, K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03405-8 · Cited by 326
Venous Thromboembolism in Inflammatory Bowel Disease
Solem, C. A., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04026.x · Cited by 317
Lüttges, J., Zamboni, G., Longnecker, D., & Klöppel, G. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200107000-00014 · Cited by 270
Facciorusso, A., Di Maso, M., & Muscatiello, N. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1127434 · Cited by 267
Immunomodulatory and antimicrobial effects of vitamin C
Mousavi, S., Bereswill, S., & Heimesaat, M. M. (2019) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00016 · Cited by 266
Nutritional deficiencies in patients with Crohnʼs disease in remission
Filippi, J., Al-Jaouni, R., Wiroth, J.-B., Hébuterne, X., & Schneider, S. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000206541.15963.c3 · Cited by 263
Light scattering from cells: the contribution of the nucleus and the effects of proliferative status
Mourant, J. R., Canpolat, M., Brocker, C., Esponda-Ramos, O., Johnson, T. M., Matanock, A., Stetter, K., & Freyer, J. P. (2000) · Journal of Biomedical Optics · doi:10.1117/1.429979 · Cited by 261
Strategies for the management of hepatocellular carcinoma
Schwartz, M., Roayaie, S., & Konstadoulakis, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0844 · Cited by 261
Li, H., Wang, X., Wen, C., Huo, Z., Wang, W., Zhan, Q., Cheng, D., Chen, H., Deng, X., Peng, C., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0738-0 · Cited by 260
Leng, J., Han, C., Demetris, J. A., Michalopoulos, G. K., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50380 · Cited by 258
The synthesis of proteoglycans in fat-storing cells of rat liver
Schäfer, S., Zerbe, O., & Gressner, A. M. (1987) · Hepatology · doi:10.1002/hep.1840070411 · Cited by 255
Leroy, V., Monier, F., Bottari, S., Trocme, C., Sturm, N., Hilleret, M.-N., Morel, F., & Zarski, J.-P. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04055.x · Cited by 255
Interferons: Success in anti-viral immunotherapy
Lin, F.-C., & Young, H. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.015 · Cited by 254
Portal vein thrombosis; risk factors, clinical presentation and treatment
Sogaard, K. K., Astrup, L. B., Vilstrup, H., & Gronbaek, H. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-34 · Cited by 217
Peterson, C. G., Eklund, E., Taha, Y., Raab, Y., & Carlson, M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05837.x · Cited by 137
Pancreatic cancer subtypes: a roadmap for precision medicine
Torres, C., & Grippo, P. J. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1453168 · Cited by 104
Omeprazole produces parietal cell hypertrophy and hyperplasia in humans
Driman, D. K., Wright, C., Tougas, G., & Riddell, R. H. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093608 · Cited by 96
Cazanave, S., Podtelezhnikov, A., Jensen, K., Seneshaw, M., Kumar, D. P., Min, H.-K., Santhekadur, P. K., Banini, B., Mauro, A. G., M. Oseini, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17370-6 · Cited by 66
Adverse Reactions and Interactions with H2-Receptor Antagonists
Pension, J., & Wormsley, K. G. (1986) · Medical Toxicology · doi:10.1007/bf03259837 · Cited by 63
Bugs or drugs: Are probiotics safe for use in the critically ill?
Urben, L. M., Wiedmar, J., Boettcher, E., Cavallazzi, R., Martindale, R. G., & McClave, S. A. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0388-y · Cited by 29
Xu, W., Kwon, J.-H., Moon, Y. H., Kim, Y. B., Yu, Y. S., Lee, N., Choi, K. Y., Kim, Y. S., Park, Y. K., Kim, B. W., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1713-4 · Cited by 29
Metadata
- Venue
- Hepatogastroenterology
- Publisher
- Update Medical Publishing
- Published
- 2012-04-05
- Volume
- 59
- Issue
- 115
- Pages
- 680-6
- ISSN
- 0172-6390 (ISSN-L)
- OpenAlex
- W318069809
- Cited by
- 1,625
- References
- 0
- Type
- paratext
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.